E2A proteins are required for proper B cell development and initiation of immunoglobulin gene rearrangements
暂无分享,去创建一个
Ian Krop | Anton Berns | A. Feeney | A. Berns | C. Murre | M. Schlissel | H. Riele | D. Izon | M. Valk | A. Kruisbeek | I. Krop | D. Amsen | Cornelis Murre | G. Bain | Mark S. Schlissel | Ann J. Feeney | Derk Amsen | Gretchen Bain | Els C.Robanus Maandag | David J. Izon | Ada M. Kruisbeek | Bennett C. Weintraub | Marian van Roon | Martin van der Valk | Hein P.J. te Riele | B. Weintraub | E. C. Maandag | M. Roon | Mark Schlissel
[1] L. Su,et al. The immunoglobulin heavy-chain enhancer functions as the promoter for I mu sterile transcription , 1990, Molecular and cellular biology.
[2] C. Vierra,et al. E2A expression, nuclear localization, and in vivo formation of DNA- and non-DNA-binding species during B-cell development , 1993, Molecular and cellular biology.
[3] H. Weintraub,et al. The helix-loop-helix gene E2A is required for B cell formation , 1994, Cell.
[4] F. Alt,et al. Restoration of T cell development in RAG-2-deficient mice by functional TCR transgenes. , 1993, Science.
[5] K. Rajewsky,et al. Immunoglobulin heavy and light chain genes rearrange independently at early stages of B cell development , 1993, Cell.
[6] G. Church,et al. B lineage--specific interactions of an immunoglobulin enhancer with cellular factors in vivo. , 1985, Science.
[7] V. Stewart,et al. RAG-2-deficient mice lack mature lymphocytes owing to inability to initiate V(D)J rearrangement , 1992, Cell.
[8] J R Matthews,et al. Structure and function of helix-loop-helix proteins. , 1994, Biochimica et biophysica acta.
[9] G. Lennon,et al. Cμ-containing transcripts initiate heterogeneously within the IgH enhancer region and contain a novel 5′-nontranslatable exon , 1985, Nature.
[10] M. Monk,et al. HPRT-deficient (Lesch–Nyhan) mouse embryos derived from germline colonization by cultured cells , 1987, Nature.
[11] D. Baltimore,et al. Virus-transformed pre-B cells show ordered activation but not inactivation of immunoglobulin gene rearrangement and transcription , 1991, The Journal of experimental medicine.
[12] F. Alt,et al. Development of the primary antibody repertoire. , 1987, Science.
[13] C. Nelson,et al. Functional analysis of the murine T-cell receptor beta enhancer and characteristics of its DNA-binding proteins , 1990, Molecular and cellular biology.
[14] X. F. Wang,et al. In vivo functional analysis of in vitro protein binding sites in the immunoglobulin heavy chain enhancer. , 1988, Nucleic Acids Research.
[15] G. Church,et al. Cell-type-specific contacts to immunoglobulin enhancers in nuclei , 1985, Nature.
[16] C. Murre,et al. Localization of E2A mRNA expression in developing and adult rat tissues. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[17] M. Busslinger,et al. The promoter of the CD19 gene is a target for the B-cell-specific transcription factor BSAP , 1992, Molecular and cellular biology.
[18] A. Barberis,et al. A novel B-cell lineage-specific transcription factor present at early but not late stages of differentiation. , 1990, Genes & development.
[19] A. Aronheim,et al. Distribution and characterization of helix-loop-helix enhancer-binding proteins from pancreatic beta cells and lymphocytes. , 1991, Nucleic acids research.
[20] M. Capecchi,et al. Site-directed mutagenesis by gene targeting in mouse embryo-derived stem cells , 1987, Cell.
[21] Y. Jan,et al. Interactions between heterologous helix-loop-helix proteins generate complexes that bind specifically to a common DNA sequence , 1989, Cell.
[22] D. Baltimore,et al. Helix-loop-helix transcription factor E47 activates germ-line immunoglobulin heavy-chain gene transcription and rearrangement in a pre-T-cell line. , 1991, Genes & development.
[23] D. Baltimore,et al. Protein-binding sites in Ig gene enhancers determine transcriptional activity and inducibility. , 1987, Science.
[24] A. Feeney. Predominance of the prototypic T15 anti-phosphorylcholine junctional sequence in neonatal pre-B cells. , 1991, Journal of immunology.
[25] C. Murre,et al. E2A and E2-2 are subunits of B-cell-specific E2-box DNA-binding proteins , 1993, Molecular and cellular biology.
[26] A. Berns,et al. Highly efficient gene targeting in embryonic stem cells through homologous recombination with isogenic DNA constructs. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[27] David Baltimore,et al. A new DNA binding and dimerization motif in immunoglobulin enhancer binding, daughterless, MyoD, and myc proteins , 1989, Cell.
[28] M. Groudine,et al. Helix-loop-helix transcription factors E12 and E47 are not essential for skeletal or cardiac myogenesis, erythropoiesis, chondrogenesis, or neurogenesis. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[29] S. Desiderio,et al. Coordination of immunoglobulin DJH transcription and D-to-JH rearrangement by promoter-enhancer approximation , 1991, Molecular and cellular biology.
[30] A. Glasebrook,et al. IgG or IgM monoclonal antibodies reactive with different determinants on the molecular complex bearing Lyt 2 antigen block T cell-mediated cytolysis in the absence of complement. , 1980, Journal of immunology.
[31] A. Kudo,et al. A pre‐B‐ and B cell‐specific DNA‐binding protein, EBB‐1, which binds to the promoter of the VpreB1 gene , 1992, European journal of immunology.
[32] A. Feeney,et al. Lack of N regions in fetal and neonatal mouse immunoglobulin V-D-J junctional sequences , 1990, The Journal of experimental medicine.
[33] F. Alt,et al. Influence of immunoglobulin heavy- and light-chain expression on B-cell differentiation. , 1994, Genes & development.
[34] A. Feeney. Predominance of VH-D-JH junctions occurring at sites of short sequence homology results in limited junctional diversity in neonatal antibodies. , 1992, Journal of immunology.
[35] R. Stein,et al. Identification of a pancreatic beta-cell insulin gene transcription factor that binds to and appears to activate cell-type-specific expression: its possible relationship to other cellular factors that bind to a common insulin gene sequence , 1990, Molecular and cellular biology.
[36] A. Smith,et al. Buffalo rat liver cells produce a diffusible activity which inhibits the differentiation of murine embryonal carcinoma and embryonic stem cells. , 1987, Developmental biology.
[37] F. Sablitzky,et al. V(D)J recombination in B cells is impaired but not blocked by targeted deletion of the immunoglobulin heavy chain intron enhancer. , 1993, The EMBO journal.
[38] H. Land,et al. A series of mammalian expression vectors and characterisation of their expression of a reporter gene in stably and transiently transfected cells. , 1990, Nucleic acids research.
[39] P. Marrack,et al. Characterization of a monoclonal antibody which detects all murine alpha beta T cell receptors. , 1989, Journal of immunology.
[40] D. Baltimore,et al. Functional immunoglobulin transgenes guide ordered B-cell differentiation in Rag-1-deficient mice. , 1994, Genes & development.
[41] L. Hood,et al. Separate elements control DJ and VDJ rearrangement in a transgenic recombination substrate. , 1990, The EMBO journal.
[42] K. Rajewsky,et al. A critical role of λ5 protein in B cell development , 1992, Cell.
[43] Xiao-Hong Sun. Constitutive expression of the Id1 gene impairs mouse B cell development , 1994, Cell.
[44] David Baltimore,et al. Multiple nuclear factors interact with the immunoglobulin enhancer sequences , 1986, Cell.
[45] D. Schatz,et al. The recombination activating gene-1 (RAG-1) transcript is present in the murine central nervous system , 1991, Cell.
[46] V. Stewart,et al. Mutations of the intronic IgH enhancer and its flanking sequences differentially affect accessibility of the JH locus. , 1993, The EMBO journal.
[47] Susumu Tonegawa,et al. RAG-1-deficient mice have no mature B and T lymphocytes , 1992, Cell.
[48] David Baltimore,et al. Functional activity of myogenic HLH proteins requires hetero-oligomerization with E12/E47-like proteins in vivo , 1991, Cell.
[49] J D Kemp,et al. Resolution and characterization of pro-B and pre-pro-B cell stages in normal mouse bone marrow , 1991, The Journal of experimental medicine.